The MicroRNA Revolution
Working at Harvard University and Massachusetts General Hospital, Drs. Victor Ambros and Gary Ruvkun and their groups identified and characterized the first microRNA. Dr. Ambros' laboratory yielded the discovery of the first microRNA and Dr. Ruvkun's laboratory identified how that microRNA regulates its target messenger. Together, they demonstrated that the microRNA inactivates its target through direct, base-pairing interactions. Since their discovery, the small RNA field has grown to thousands of papers, many focused on particular diseases and potential treatments. The research has come full circle — from fundamental biology to medicine, and today we recognize that the human genome contains perhaps as many as 1000 microRNAs that serve as pivotal regulators of both normal and disease physiology. In recognition of their role in the discovery of microRNA, Drs. Ambros and Ruvkun will receive the 2012 Dr. Paul Janssen Award for Biomedical Research.
This symposium will honor Ambros and Ruvkun, who will each reflect upon their early discoveries and ongoing research to better understand the molecular mechanisms by which microRNAs regulate gene expression. MicroRNAs have since been shown to play a critical role in embryonic development, blood-cell specialization, cancer, muscle function, metabolism, aging, heart disease, inflammation, viral infections, stem-cell behavior and neurological signaling. Following the Award lectures, leading scientists in the microRNA field will discuss new insights in the mechanism of microRNA-mediated target repression and specific microRNAs that are currently being pursued as diagnostic and prognostic indicators as well as clinical therapeutics.
Featured Speakers and Panelists:
- Victor Ambros, PhD University of Massachusetts Medical School
- Gregory J. Hannon, PhD Cold Spring Harbor Laboratories, Howard Hughes Medical Institute
- Seema Kumar Janssen Pharmaceutical Companies of Johnson & Johnson
- Eric C. Lai, PhD Memorial Sloan-Kettering Cancer Center
- Gary Ruvkun, PhD Massachusetts General Hospital and Harvard Medical School
- Paul Stoffels, MD Worldwide Chairman, Pharmaceuticals, Johnson & Johnson
Join Metanexus Today
Metanexus fosters a growing international network of individuals and groups exploring the dynamic interface between cosmos, nature and culture. Membership is open to all. Join Now!